 Connection
Suchitra Rao to Antiviral Agents
This is a "connection" page, showing publications Suchitra Rao has written about Antiviral Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.062 |
|
|
|
-
Williams JT, Cunningham MA, Wilson KM, Rao S. Rising Oseltamivir Use Among Hospitalized Children in a Postpandemic Era. Hosp Pediatr. 2016 Mar; 6(3):172-8.
Score: 0.331
-
Rao S, Abzug MJ, Carosone-Link P, Peterson T, Child J, Siparksy G, Soranno D, Cadnapaphornchai MA, Sim?es EA. Intravenous acyclovir and renal dysfunction in children: a matched case control study. J Pediatr. 2015 Jun; 166(6):1462-8.e1-4.
Score: 0.312
-
Bassett HK, Rao S, Beck J, Brady PW, Jhaveri R, Joerger T, Liang D, Quinonez R, Shine A, Malec J, Lucas BP, Schroeder AR. Variability of Clinician Recommendations for Oseltamivir in Children Hospitalized With Influenza. Pediatrics. 2025 May 01; 155(5).
Score: 0.158
-
Frutos AM, Ahmad HM, Ujamaa D, O'Halloran AC, Englund JA, Klein EJ, Zerr DM, Crossland M, Staten H, Boom JA, Sahni LC, Halasa NB, Stewart LS, Hamdan O, Stopczynski T, Schaffner W, Talbot HK, Michaels MG, Williams JV, Sutton M, Hendrick MA, Staat MA, Schlaudecker EP, Tesini BL, Felsen CB, Weinberg GA, Szilagyi PG, Anderson BJ, Rowlands JV, Khalifa M, Martinez M, Selvarangan R, Schuster JE, Lynfield R, McMahon M, Kim S, Nunez VT, Ryan PA, Monroe ML, Wang YF, Openo KP, Meek J, Yousey-Hindes K, Alden NB, Armistead I, Rao S, Chai SJ, Kirley PD, Toepfer AP, Dawood FS, Moline HL, Uyeki TM, Ellington S, Garg S, Bozio CH, Olson SM. Underutilization of Influenza Antiviral Treatment Among Children and Adolescents at Higher Risk for Influenza-Associated Complications - United States, 2023-2024. MMWR Morb Mortal Wkly Rep. 2024 Nov 14; 73(45):1022-1029.
Score: 0.153
-
Bose-Brill S, Hirabayashi K, Schwimmer E, Pajor NM, Rao S, Mejias A, Jhaveri R, Forrest CB, Bailey LC, Christakis DA, Thacker D, Hanley PC, Patel PB, Cogen JD, Block JP, Prahalad P, Lorman V, Lee GM. Pediatric Nirmatrelvir/Ritonavir Prescribing Patterns During the COVID-19 Pandemic. Hosp Pediatr. 2024 08 01; 14(8):e341-e348.
Score: 0.038
-
Smith-Jeffcoat SE, Biddle JE, Talbot HK, Morrissey KG, Stockwell MS, Maldonado Y, McLean HQ, Ellingson KD, Bowman NM, Asturias E, Mellis AM, Johnson S, Kirking HL, Rolfes MAR, Olivo V, Merrill L, Battan-Wraith S, Sano E, McLaren SH, Vargas CY, Goodman S, Sarnquist CC, Govindaranjan P, Petrie JG, Belongia EA, Ledezma K, Pryor K, Lutrick K, Bullock A, Yang A, Haehnel Q, Rao S, Zhu Y, Schmitz J, Hart K, Grijalva CG, Salvatore PP. Symptoms, Viral Loads, and Rebound Among COVID-19 Outpatients Treated With Nirmatrelvir/Ritonavir Compared With Propensity Score-Matched Untreated Individuals. Clin Infect Dis. 2024 05 15; 78(5):1175-1184.
Score: 0.037
-
Britton A, Embi PJ, Levy ME, Gaglani M, DeSilva MB, Dixon BE, Dascomb K, Patel P, Schrader KE, Klein NP, Ong TC, Natarajan K, Hartmann E, Kharbanda AB, Irving SA, Dickerson M, Dunne MM, Raiyani C, Grannis SJ, Stenehjem E, Zerbo O, Rao S, Han J, Sloan-Aagard C, Griggs EP, Weber ZA, Murthy K, Fadel WF, Grisel N, McEvoy C, Lewis N, Barron MA, Nanez J, Reese SE, Mamawala M, Valvi NR, Arndorfer J, Goddard K, Yang DH, Fireman B, Ball SW, Link-Gelles R, Naleway AL, Tenforde MW. Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022. MMWR Morb Mortal Wkly Rep. 2022 Oct 21; 71(42):1335-1342.
Score: 0.033
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|